The One Biotech Stock That Looks Like a Bargain These Days
Over the course of this long bull market, biotech stocks have been very, very good for their owners. Perhaps too good. Investors have shown such rabid enthusiasm for biotechs—especially small, unproven companies that have yet to bring a drug to market—that some observers are using another b word to describe the high-flying sector: bubble.See Also: 8 Stocks Under $10 Worth […]